Interactive tool · Anti-doping status
WADA Prohibited-Status Checker
Look up a peptide or drug on the 2026 WADA Prohibited List to see its status, class and what it means for tested athletes.
Informational only. An absent substance is not proof it is allowed. Confirm with the official WADA List and your anti-doping authority.
Read before you use this
This is an informational compliance tool, not anti-doping advice and not guidance on how to avoid detection. It reflects the WADA 2026 Prohibited List as published; the List is updated annually and your sport or anti-doping organization may have additional rules. A substance not appearing here is not proof it is allowed — any unapproved research substance can be prohibited under S0. Many of these peptides are also sold on a gray market with unverified contents, which is itself a documented route to a positive test. If you compete in a tested sport, always confirm against the live, official WADA Prohibited List and consult your anti-doping authority before acting.
The 2027 WADA List takes effect January 1, 2027. This checker shows the 2026 list. Read the 2027 peptide changes.
Type a peptide above or pick one from the list to see its 2026 WADA status.
The full 2026 table
| Substance / class | Status | WADA class |
|---|---|---|
| Testosterone (TRT and all anabolic androgenic steroids) | Prohibited | S1 |
| Enclomiphene and other SERMs | Prohibited | S4 |
| NAD+ (nicotinamide adenine dinucleotide) | No entry — not the same as allowed | Not listed (but see M2, infusions) |
| BPC-157 | Prohibited | S0 |
| TB-500 | Prohibited | S0 / S2 |
| GH-releasing peptides (GHRP family) | Prohibited | S2 |
| GHRH analogs (sermorelin / CJC-1295 / tesamorelin) | Prohibited | S2 |
| Growth hormone (hGH / somatropin) | Prohibited | S2 |
| HGH fragment 176-191 | Prohibited | S2 |
| AOD-9604 | Prohibited | S2 |
| IGF-1 / IGF-1 LR3 / mechano growth factor | Prohibited | S2 |
| Follistatin / ACE-031 (myostatin inhibitors) | Prohibited | S2 |
| Pegmolesatide (EPO mimetic) | Prohibited | S2 |
| Retatrutide | Prohibited | S0 |
| SLU-PP-332 | Prohibited | S0 |
| Semaglutide (Ozempic / Wegovy) | Monitoring Program — not banned | Monitoring Program |
| Tirzepatide (Mounjaro / Zepbound) | Monitoring Program — not banned | Monitoring Program |
How to read this. “Prohibited” means prohibited at all times on the 2026 List. S2 = peptide hormones, growth factors, related substances and mimetics. S0 = any substance with no approved human therapeutic use anywhere (which catches research-only peptides). The Monitoring Program is surveillance that sits outside the Prohibited List — substances there are NOT banned while monitored, but their status can change. This table reflects the WADA 2026 List as published; it is not personalized anti-doping advice. Always confirm against the live official List and your sport's rules.
The detail behind the status
A status badge is the short answer. How WADA classifies these peptides, what changed in 2026, and how detection actually works are the parts that matter for a tested athlete:
This checker is informational and not anti-doping advice. It reproduces the WADA 2026 Prohibited List status for a curated set of peptides and peptide-adjacent drugs and does not account for sport-specific rules, therapeutic use exemptions, product contamination, or future changes to the List. Most research peptides are not FDA-approved, are sold on the gray market with unverified purity, and are prohibited in tested sport. Always verify against the live official WADA List and your own anti-doping authority before acting.